Biogen Inc (NASDAQ: BIIB)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 12/23/2022
Closing price: 279.16
|Support price level:||$267.07|
|Resistance price level:||$293.91|
|Relative strength index (14-day RSI)||31.1|
- Volatility is forecast to fall over the next month.
- BIIB is above its 200-day moving average, providing a measure of support for long positions.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 11.8% in the next week.
- 27.2% in the next month.
- 91.4% in the next year.
Company news for Biogen IncGoogle Finance | MarketWatch | WSJ
Analysis for other Health Care stocks